Blog Posts (47)
September 30, 2015
Cancer drugs have become increasingly expensive in recent years. No one blinks anymore when a new lung cancer or colon cancer treatment comes to market priced at more than $100,000 per patient. In part, we don’t blink because we have … Continue reading →
The post Cancer Drugs Aren’t As Cost-Effective As They Used To Be appeared first on PeterUbel.com.
September 25, 2015
If she had been eligible for Medicare, the hospital would have charged the government $10,000 for the services it provided to her, with Medicare picking up most of the tab. But lacking insurance, she was billed directly from the hospital, … Continue reading →
The post Want to Pay Higher Prices? Try a For-Profit Hospital! appeared first on PeterUbel.com.
September 24, 2015
Greedy pharma execs have been in the news of late. Here is a story on the topic, from Wired. The reporter misquotes me. I never said Apple could make profits selling iPhones for $10. I said that even if … Continue reading →
The post What’s a Fair Price for a Medication? appeared first on PeterUbel.com.
September 23, 2015
The bill she received in the mail revealed a staggering figure — $9,225 for one infusion of Avastin, a chemotherapy drug. And she would need many more such infusions. Fortunately, the dollar amount is what medical experts call a “charge,” … Continue reading →
The post Are Medicare Prescription Benefits Too Stingy? appeared first on PeterUbel.com.
September 17, 2015
The federal government is currently debating whether the big six health insurance companies in the U.S. will soon become the big four. Aetna and Humana have announced plans to merge, as have Anthem and Cigna. The American Hospital Association and … Continue reading →
The post Merger Mania in Medicine — What Will It Cost Us? appeared first on PeterUbel.com.
September 3, 2015
For more than half a century now, the United States has stood out among its peers in the developed world for having the largest percent of its citizens living without health insurance. But once you turn 65-years-old in America, the … Continue reading →
The post Medicare, Schmedicare appeared first on PeterUbel.com.
August 27, 2015
Under the Affordable Care Act, the percent of Americans who lack any health insurance has declined significantly. Put another way – more Americans have health insurance than ever. But having insurance coverage is different than being well covered by insurance. Sometimes a … Continue reading →
The post Insured But Not Covered appeared first on PeterUbel.com.
August 14, 2015
There has been lots written lately about the soaring cost of cancer care. You’re spending a lot on cancer recently in part because of many wonderful new treatments that come with a substantial price tag. But there has been less … Continue reading →
The post Which Cancers Do We Spend Most of Our Money On? appeared first on PeterUbel.com.
August 12, 2015
Here is a link to a story from one of my favorite reporters, Rebecca Plavin from KPCC radio in California. She uncovered a startup company the tries to help people shop for healthcare services, by letting them name their price … Continue reading →
The post Priceline for Healthcare Services? appeared first on PeterUbel.com.
August 7, 2015
Recently, I showed some data illustrating the rapid growth in healthcare jobs in the United States, compared to jobs in other parts of the economy. Here’s a picture, courtesy of Dan Diamond, showing that this growth has not been steady. … Continue reading →
The post Surge in Hospital Job Growth appeared first on PeterUbel.com.
View More Blog Entries
June 19, 2013 3:08 pm
Unfortunately, limited by many factors, our health-care system has suffered from insufficient experimentation and a lack of innovation in approaches to physician and nonphysician provider compensation.
May 21, 2012 4:55 pm
Think of it as a health policy wonk’s dream: Football stadium after
One insurance company’s data could fill 60 million of these. (bigstockphoto) football stadium packed to the brim with…health insurance claims data. An odd dream, to be sure. But health insurance data is crucial to understand how health care dollars get spent. It shows how people use health care, what’s changing and, in some cases, why. Health insurers, however, have tended to keep that data private, as it could tip competitors off to how they handle business.
May 20, 2012 1:37 pm
Having the results of a personalized genetic test did not drive patients to utilize potentially costly follow-up healthcare services, a study from the National Institutes of Health (NIH) found. In the past five years, there have been many new tests marketed to consumers who want to know whether they are genetically susceptible to a range of health conditions and traits, including diabetes and certain types of cancers. The tests, known as multiplex assays when they test for a variety of genetic variations, are marketed by a number of for-profit companies.
May 14, 2012 10:14 am
An Irish adage says: “When you come to a wall that is too high to climb, throw your hat over the wall, and then go get your hat.” That’s what Massachusetts started with its 2006 law requiring just about everyone to get coverage and arranging to make that coverage affordable. Now, it’s time to get the hat.
April 30, 2012 10:37 am
Worried that questioning your doctor will damage your relationship or make for an awkward office visit? Time to untie your tongue. Asking a few key questions at your next appointment could save you both money and exposure to medical risks. Meanwhile, more doctors are volunteering to help the conversation along and prescribe evidence-based conservative measures first.
April 12, 2012 11:39 pm
Spurred by patients and patient advocates like Ms. Kuhn, lawmakers in at least 20 states, from Maine to Hawaii, have introduced bills that would limit out-of-pocket payments by consumers for expensive drugs used to treat diseases like cancer,rheumatoid arthritis, multiple sclerosis and inherited disorders.
April 5, 2012 12:57 pm
The national conversation about health care reform focuses relentlessly on cost reduction. While bending the cost curve is extremely important, improving quality is also essential — but sometimes downplayed — in today’s reform equation. Grappling with quality challenges has attracted a new breed of health care leaders: physician and nurse executives.